Identification of platelet-derived growth factor D in human chronic allograft nephropathy

Human Pathology

Volumn 39, Issue 3, 2008, Pages 393-402

  Liu, Gang ^a   Changsirikulchai, Siribha ^b   Hudkins, Kelly L ^c   Banas, Miriam C ^d   Kowalewska, Jolanta ^c   Yang, Xiangling ^c   Wietecha, Tomasz A ^c   Volpone, John ^e   Gilbertson, Debra G ^e   Alpers, Charles E ^c  

^a PEKING UNIVERSITY   (China)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Klin und Poliklin F Inn Med I   (Germany)

^e ZYMOGENETICS INC   (United States)

Author keywords

Allograft; Nephropathy; PDGF D; Transplantation

Indexed keywords

PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR D;

ANTIBODY LABELING; ARTERY DISEASE; ARTICLE; CELL TYPE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTIMA; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEPHRECTOMY; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LYMPHOKINES; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RENAL ARTERY; TRANSPLANTATION, HOMOLOGOUS;

EID: 39049102406     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.07.008     Document Type: Article

References (34)

1. Paul L.C. Chronic allograft nephropathy: an update. Kidney Int 56 (1999) 783-793
2. Seron D. Early diagnosis of chronic allograft nephropathy by means of protocol biopsies. Transplant Proc 36 (2004) 763-764
3. Aull M.J. Chronic allograft nephropathy: pathogenesis and management of an important posttransplant complication. Prog Transplant 14 (2004) 82-88
4. Bonner J.C. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 15 (2004) 255-273
5. Betsholtz C. Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev 15 (2004) 215-228
6. Hudkins K.L., Gilbertson D.G., Carling M.D., et al. Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy. J Am Soc Nephrol 15 (2004) 286-298
7. Alpers C.E., Davis C.L., Barr D., Marsh C.L., and Hudkins K.L. Identification of platelet-derived growth factor A and B chains in human renal vascular rejection. Am J Pathol 148 (1996) 439-451
8. Fredriksson L., Li H., and Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 15 (2004) 197-204
9. Floege J., Eitner F., Van Roeyen C., and Ostendorf T. PDGF-D and renal disease: yet another one of those growth factors?. J Am Soc Nephrol 14 (2003) 2690-2691
10. Reigstad L.J., Varhaug J.E., and Lillehaug J.R. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. Febs J 272 (2005) 5723-5741
11. Uehara G., Suzuki D., Toyoda M., Umezono T., and Sakai H. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy. Clin Exp Nephrol 8 (2004) 36-42
12. Taneda S., Hudkins K.L., Topouzis S., et al. Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J Am Soc Nephrol 14 (2003) 2544-2555
13. Floege J., Hudkins K.L., Davis C.L., Schwartz S.M., and Alpers C.E. Expression of PDGF alpha-receptor in renal arteriosclerosis and rejecting renal transplants. J Am Soc Nephrol 9 (1998) 211-223
14. Ostendorf T., van Roeyen C.R., Peterson J.D., et al. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J Am Soc Nephrol 14 (2003) 2237-2247
15. Lutz J., Yao Y., Song E., et al. Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats. Transplantation 79 (2005) 655-661
16. Savikko J., Taskinen E., and Von Willebrand E. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy. Transplantation 75 (2003) 1147-1153
17. Schindler R., Tullius S.G., Tanriver Y., et al. Hypertension increases expression of growth factors and MHC II in chronic allograft nephropathy. Kidney Int 63 (2003) 2302-2308
18. Akyurek L.M., Paul L.C., Funa K., Larsson E., and Fellstrom B.C. Smooth muscle cell migration into intima and adventitia during development of transplant vasculopathy. Transplantation 62 (1996) 1526-1529
19. Chen J., Han Y., Lin C., et al. PDGF-D contributes to neointimal hyperplasia in rat model of vessel injury. Biochem Biophys Res Commun 329 (2005) 976-983
20. Changsirikulchai S., Hudkins K.L., Goodpaster T.A., et al. Platelet-derived growth factor-D expression in developing and mature human kidneys. Kidney Int 62 (2002) 2043-2054
21. Alpers C.E., Seifert R.A., Hudkins K.L., Johnson R.J., and Bowen-Pope D.F. PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int 43 (1993) 286-294
22. Colvin R.B., Cohen A.H., Saiontz C., et al. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 8 (1997) 1930-1941
23. Racusen L.C., Colvin R.B., Solez K., et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3 (2003) 708-714
24. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 (1999) 713-723
25. Skalli O., Ropraz P., Trzeciak A., Benzonana G., Gillessen D., and Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 103 6 Pt 2 (1986) 2787-2796
26. Holthofer H., Virtanen I., Kariniemi A.L., Hormia M., Linder E., and Miettinen A. Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest 47 (1982) 60-66
27. Falini B., Flenghi L., Pileri S., et al. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 142 (1993) 1359-1372
28. Hudkins K.L., Giachelli C.M., Cui Y., Couser W.G., Johnson R.J., and Alpers C.E. Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol 10 (1999) 444-457
29. Wieczorek G., Bigaud M., Menninger K., et al. Acute and chronic vascular rejection in nonhuman primate kidney transplantation. Am J Transplant 6 (2006) 1285-1296
30. Palumbo R., Gaetano C., Antonini A., et al. Different effects of high and low shear stress on platelet-derived growth factor isoform release by endothelial cells: consequences for smooth muscle cell migration. Arterioscler Thromb Vasc Biol 22 (2002) 405-411
31. Raines E.W. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15 (2004) 237-254
32. Tang W.W., Ulich T.R., Lacey D.L., et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148 (1996) 1169-1180
33. Yu J., Moon A., and Kim H.R. Both platelet-derived growth factor receptor (PDGFR)-alpha and PDGFR-beta promote murine fibroblast cell migration. Biochem Biophys Res Commun 282 (2001) 697-700
34. Oh S.J., Kurz H., Christ B., and Wilting J. Platelet-derived growth factor-B induces transformation of fibrocytes into spindle-shaped myofibroblasts in vivo. Histochem Cell Biol 109 (1998) 349-357